Latest News and Press Releases
Want to stay updated on the latest news?
-
OSLO, NORWAY--(Marketwire - Jun 7, 2012) - Bionor Pharma ASA (OSLO: BIONOR) announced today that it has initiated the international patent process for protection of the Company's peptide vaccine...
-
OSLO, NORWAY--(Marketwire - Jun 7, 2012) - Bionor Pharma ASA (OSLO: BIONOR) News Summary The new patent filed 6 June aims to strengthen the Company's general protection of its...
-
OSLO, NORWAY--(Marketwire - May 29, 2012) - Bionor Pharma ASA (OSLO: BIONOR) News Summary Open, clinical study, dose escalating, phase I/II, with Bionor...
-
OSLO, NORWAY--(Marketwire - May 11, 2012) - Bionor Pharma ASA (OSLO: BIONOR) announced today unanimously shareholder approval for new and re-elected Board members to the Board of Directors, and...
-
OSLO, NORWAY--(Marketwire - May 10, 2012) - Bionor Pharma (OSLO: BIONOR) News Summary Vaccine related immune responses found in HIV patients given Vacc-4x...
-
WASHINGTON, DC--(Marketwire - Apr 19, 2012) - Today the National Association of People with AIDS (NAPWA) and the Treatment Access Expansion Project (TAEP) announces AIDSWatch 2012, the largest...
-
WASHINGTON, DC and DALLAS, TX--(Marketwire - Apr 6, 2012) - The National Association of People with AIDS (NAPWA) today announced that it will host the first annual National Healthy Living Summit...
-
VENTURA, CA--(Marketwire - Mar 6, 2012) - Lymphedema Awareness Day was established to support the needs of patients with lymphedema and to raise awareness for the need to develop new treatment...
-
OSLO, NORWAY--(Marketwire - Feb 15, 2012) - Bionor Pharma (OSLO: BIONOR) News Summary Final review of phase IIb data confirms statistically significant 64%...
-
OSLO, NORWAY--(Marketwire - Jan 23, 2012) - News Summary Bionor Pharma ASA has previously submitted two international patent applications for the Company's...